Navigation Links
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
Date:6/11/2008

of development as a biopharmaceutical company, government regulation and healthcare reform, technological uncertainty and product development risks, product liability exposure, uncertainty of additional funding, CuraGen's history of incurring losses and the uncertainty of achieving profitability, reliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to in CuraGen's Quarterly Report on Form 10-Q for the period ended March 31, 2008, filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, CuraGen's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Glenn Schulman, PharmD

Director of Medical Communications

gschulman@curagen.com

(888) 436-6642

CRGN-P


'/>"/>
SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Israel , June 29, 2015 ... today announced positive preliminary results from its BVX-006 Phase ... universal influenza vaccine. In this trial, M-001 was injected ... 65, followed by an administration of the 2014/15 season ... found to be safe and well tolerated and induced ...
(Date:6/29/2015)... , June 29, 2015 Regeneron ... that the Proceedings of the National Academy ... demonstrating that the Company,s proprietary VelociGene ® ... identification and preclinical validation of potential candidates that ... of Middle East Respiratory Syndrome (MERS). This involved ...
(Date:6/29/2015)... , June 29, 2015 The global ... by 2020, according to a new study by Grand View Research, ... and the presence of high unmet needs in emerging markets such ... are expected to be two of the most significant growth ... diseases such as obesity and growing global geriatric population base are ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4
... 2011 Merrimack Pharmaceuticals, Inc. announced today that ... randomized Phase 2 clinical trial of MM-121, a ... with paclitaxel (Taxol®) in the neoadjuvant setting of ... The Phase 2 study is designed ...
... Calif., Oct. 11, 2011 Codexis, Inc. (Nasdaq: ... has been named Director, Latin America. He will head ... for managing Codexis, expanding role in Latin America. He ... and SVP, Process Development and Manufacturing. ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients 2Codexis Names Veteran Chemical Executive to Lead Codexis do Brasil 2Codexis Names Veteran Chemical Executive to Lead Codexis do Brasil 3
(Date:6/30/2015)... ... June 30, 2015 , ... Alice Branton, CEO of Trivedi ... India. During her stay, she met with the leading scientists of several ... Transformational Leader/Internationally Beloved Spiritual Master Mahendra Trivedi to develop highly advanced products for ...
(Date:6/30/2015)... ... June 30, 2015 , ... Skin Brushing (also known as Body Brushing) is a wonderful daily ... beautiful as it is more exposed to the elements. , Dry Skin Brushing takes only ... Exfoliate the dead cells and toxins on skin's surface. Skin is the largest organ ...
(Date:6/30/2015)... ... 30, 2015 , ... AvePoint, the established leader in enabling enterprise ... – AvePoint Watermark, AvePoint MyWorld, and AvePoint PDF Aggregator ... can better streamline everyday business operations and take advantage of the latest Microsoft technologies ...
(Date:6/30/2015)... ... 30, 2015 , ... Some may define success as the sum of small ... York State Athletic Trainers’ Association (NYSATA) and its members continue to be acknowledged and ... and a number of members also received honors at the national level. ...
(Date:6/30/2015)... ... 2015 , ... Intellitec Solutions has announced they will be hosting two webinars ... enhanced changes and new procedures involved with updating the cloud version of Dynamics CRM, ... the new user interface and what it will mean for end users, critical items ...
Breaking Medicine News(10 mins):Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:Intellitec Solutions to Host Microsoft CRM 2015 Update Webinar 2
... THURSDAY, Sept. 16 (HealthDay News) -- When it comes to ... cryotherapy -- works better than applying salicylic acid, another common ... cured more than half of cases, however, and better treatments ... The new finding is a bit of an about-face, according ...
... In a paper appearing in the Sept. 16 online ... professor of biology and member of the David H. ... researchers at Harvard University report a previously unknown element ... can trigger an alternative biochemical pathway that speeds up ...
... the Robert Wood Johnson Foundation Initiative on the Future of ... a blueprint for using nurse-led models of innovation to improve ... former Health and Human Services Secretary and University of Miami ... Officer at Cedars-Sinai Medical Center in Los Angeles Linda Burnes ...
... the environmental trigger that initiates and perpetuates chronic intestinal ... bowel disease (IBD), a study led by Harvard School ... bowel disease results from a loss of homeostasis, or ... inhabit the intestine. "In this study, we identified two ...
... our cells can divide is dictated by telomeres, stretches of ... keep our chromosomes and by extension, our genomes ... fields of both aging and cancer. Now, scientists at The ... structure and function of a crucial domain in the protein ...
... intensive care patients develop post-traumatic stress syndrome (PTSD) after ... is thought to be exacerbated by delusional or fragmentary ... Now researchers writing in BioMed Central,s open access journal ... and close relatives make a diary for patients, featuring ...
Cached Medicine News:Health News:For Common Warts, Freezing Therapy Works Best: Study 2Health News:For Common Warts, Freezing Therapy Works Best: Study 3Health News:MIT researchers discover an unexpected twist in cancer metabolism 2Health News:MIT researchers discover an unexpected twist in cancer metabolism 3Health News:Ways nursing can advance health care improvements: IOM to hold briefing on Oct. 5 2Health News:Bacteria identified that may lead to inflammatory bowel disease in certain individuals 2Health News:Protein clamps tight to telomeres to help prevent aging ... and support cancer 2Health News:Protein clamps tight to telomeres to help prevent aging ... and support cancer 3Health News:Intensive care diaries protect patients from PTSD 2
For regulating sample flow rate when using the QIAvac 24 Plus;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 8-multi channels...
... Filter Units,Filter units with hydrophobic PTFE ... membrane are ideal for the sterilizing ... sterile containers, and for sterilizing or ... mm Millex filter units are available ...
Medicine Products: